PEAK6’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
PEAK6's IONS Position: Q3 2026 in Review
PEAK6 reduced its Ionis Pharmaceuticals (IONS) stake by 88% in Q3 2026, selling an estimated $1.47M and leaving 3,678 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2181.
PEAK6 first reported a position in IONS in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- PEAK6 held 3,678 shares of Ionis Pharmaceuticals worth $164K as of Q3 2026.
- PEAK6 sold 25,782 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.47M.
- Ionis Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #2181 holding.
- PEAK6 first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- PEAK6's Ionis Pharmaceuticals position peaked at $2.58M in Q1 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.